This year's placement of the Indian Institute of Management (IIM) Mumbai is over. This time the placement was perfect.
The number of applications for each programme this year is as follows: General MBA: 2,69,356 applications, MBA in Operations ...
R Srikrishna, CEO and Executive Director, Hexaware Technologies--a global leader in IT services and solutions--was recognized ...
REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Mumbai announced full placement for its 2025 batch. The highest salary package reached Rs 47.5 lakh per annum, with companies ...
The Union Ministry of Education on Thursday asked the Board of Indian Institute of Management (IIM), Rohtak to either suspend institute Director Dheeraj Sharma or send him on leave till the completion ...
The inquiry will also include the verification of the educational qualification certificates of Sharma and other staff recruited at IIM. (Representative image/ Source: IIM Rohtak website) Facing graft ...
New Delhi: Facing graft allegations, IIM-Rohtak director is set to be either suspended or sent on leave by the institution’s board following directions from the government. The director, sources said, ...
The director of IIM Rohtak, Dheeraj Sharma, is under scrutiny as the board considers suspending him following directives from the government. Allegations of graft and financial misreporting have ...
The Union ministry of education on Thursday asked the Board of Indian Institute of Management (IIM), Rohtak to either suspend institute director Dheeraj Sharma or send him on leave till the ...
New Delhi, Mar 13 (PTI) The Union Ministry of Education on Thursday asked the Board of Indian Institute of Management (IIM), Rohtak to either suspend institute Director Dheeraj Sharma or send him on ...
On Tuesday, India’s top specialty generics company Sun Pharma announced the acquisition of the US-based Checkpoint for $355 million to enhance its oncology portfolio. Analysts view this ...